Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis

15 Jul 2013Havrilesky, Laura J. MD, MHSc; Moorman, Patricia G. PhD; Lowery, William J. MD; Gierisch, Jennifer M. PhD, MPH; Coeytaux, Remy R. MD, PhD; Urrutia, Rachel Peragallo MD; Dinan, Michaela PhD; McBroom, Amanda J. PhD; Hasselblad, Vic PhD; Sanders, Gillian D. PhD; Myers, Evan R. MD, MPH

Significant duration-dependent reductions in ovarian cancer incidence in the general population are associated with OCP use.

Meta Analysis
1 effect

Reported Outcomes

DeterminantsOutcomeDetails

Contraceptive pills Manufactured risk & protective factor
Protective Factor Contraceptive pills
Manufactured

Ovary cancer Reproductive outcome
Decreased risk of Ovary cancer
Reproductive system

High evidence
-50.0%